Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation

Abstract Background Pulmonary vein isolation (PVI) using conventional power (30–35 W) radiofrequency ablation (RFA) has been an effective treatment strategy for paroxysmal atrial fibrillation (PAF), but its longer duration may cause collateral damage to peripheral tissue including esophageal and phr...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:BMC Cardiovascular Disorders
المؤلفون الرئيسيون: Xinzhong Li, Zhiwen Xiao, Jiachen Zhang, Xiaobo Huang, Hairuo Lin, Senlin Huang, Yulin Liao, Juefei Wu, Jiancheng Xiu, Jianyong Li, Jianping Bin, Yuegang Wang
التنسيق: مقال
اللغة:الإنجليزية
منشور في: BMC 2025-03-01
الموضوعات:
الوصول للمادة أونلاين:https://doi.org/10.1186/s12872-025-04597-9
_version_ 1849495695022620672
author Xinzhong Li
Zhiwen Xiao
Jiachen Zhang
Xiaobo Huang
Hairuo Lin
Senlin Huang
Yulin Liao
Juefei Wu
Jiancheng Xiu
Jianyong Li
Jianping Bin
Yuegang Wang
author_facet Xinzhong Li
Zhiwen Xiao
Jiachen Zhang
Xiaobo Huang
Hairuo Lin
Senlin Huang
Yulin Liao
Juefei Wu
Jiancheng Xiu
Jianyong Li
Jianping Bin
Yuegang Wang
author_sort Xinzhong Li
collection DOAJ
container_title BMC Cardiovascular Disorders
description Abstract Background Pulmonary vein isolation (PVI) using conventional power (30–35 W) radiofrequency ablation (RFA) has been an effective treatment strategy for paroxysmal atrial fibrillation (PAF), but its longer duration may cause collateral damage to peripheral tissue including esophageal and phrenic nerve. High-power (HP) RFA, due to better transmural performance and shorter duration, may reduce the damage to adjacent tissue and is expected to be a safe and efficient ablation strategy. Methods In this retrospective cohort study, we included 259 patients with PAF who underwent lesion size index (LSI)-guided radiofrequency ablation. All patients underwent PVI-based ablation, and some underwent additional ablation, including superior vena cava isolation, tricuspid isthmus block, or left anterior atrial matrix modification. A total of 119 PAF patients underwent 50 W ablation. Complications and twelve-month arrhythmia-free outcomes of the procedure were compared with those of 140 patients who underwent 30–35 W ablation. Results PVI was successfully achieved in all patients. The procedural duration (140.3 ± 34.4 vs. 151.3 ± 40.6 min, P = 0.022) and overall radiation (112.0 ± 67.2 vs. 188.2 ± 119.2 mGy·cm2, P < 0.001) were significantly lower in the 50 W group. No major complications occurred in the high-power short-duration (HPSD) group, whereas in the conventional power group, five participants developed complications. Among them, three cases were related to venipuncture, one had pericardial tamponade, and one had slight pericardial effusion. The recurrence of arrhythmia at the twelve-month follow-up was not significantly different between the two groups [11 (9.2%) vs. 19 (13.6%), P = 0.278]. Conclusion LSI-guided HPSD-RFA was demonstrated to be comparably safe and efficacious compared to conventional ablation and resulted in reduced procedure time and radiation exposure. Graphical Abstract Central Illustration. Safety and Efficacy of Lesion Size Index Guided 50 W Radiofrequency ablation in Patients with Paroxysmal Atrial Fibrillation. A total of 259 patients with paroxysmal atrial fibrillation underwent lesion size index (LSI)-guided radiofrequency ablation were enrolled. High-Power Short-Duration ablation reduced total procedure time, significantly decreased radiation exposure, and had similar recurrence rate of atrial fibrillation.
format Article
id doaj-art-e0434aed27b74bf1a7eaaffb11ead17c
institution Directory of Open Access Journals
issn 1471-2261
language English
publishDate 2025-03-01
publisher BMC
record_format Article
spelling doaj-art-e0434aed27b74bf1a7eaaffb11ead17c2025-08-20T03:05:57ZengBMCBMC Cardiovascular Disorders1471-22612025-03-0125111010.1186/s12872-025-04597-9Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillationXinzhong Li0Zhiwen Xiao1Jiachen Zhang2Xiaobo Huang3Hairuo Lin4Senlin Huang5Yulin Liao6Juefei Wu7Jiancheng Xiu8Jianyong Li9Jianping Bin10Yuegang Wang11Department of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityClinical Research Center, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityAbstract Background Pulmonary vein isolation (PVI) using conventional power (30–35 W) radiofrequency ablation (RFA) has been an effective treatment strategy for paroxysmal atrial fibrillation (PAF), but its longer duration may cause collateral damage to peripheral tissue including esophageal and phrenic nerve. High-power (HP) RFA, due to better transmural performance and shorter duration, may reduce the damage to adjacent tissue and is expected to be a safe and efficient ablation strategy. Methods In this retrospective cohort study, we included 259 patients with PAF who underwent lesion size index (LSI)-guided radiofrequency ablation. All patients underwent PVI-based ablation, and some underwent additional ablation, including superior vena cava isolation, tricuspid isthmus block, or left anterior atrial matrix modification. A total of 119 PAF patients underwent 50 W ablation. Complications and twelve-month arrhythmia-free outcomes of the procedure were compared with those of 140 patients who underwent 30–35 W ablation. Results PVI was successfully achieved in all patients. The procedural duration (140.3 ± 34.4 vs. 151.3 ± 40.6 min, P = 0.022) and overall radiation (112.0 ± 67.2 vs. 188.2 ± 119.2 mGy·cm2, P < 0.001) were significantly lower in the 50 W group. No major complications occurred in the high-power short-duration (HPSD) group, whereas in the conventional power group, five participants developed complications. Among them, three cases were related to venipuncture, one had pericardial tamponade, and one had slight pericardial effusion. The recurrence of arrhythmia at the twelve-month follow-up was not significantly different between the two groups [11 (9.2%) vs. 19 (13.6%), P = 0.278]. Conclusion LSI-guided HPSD-RFA was demonstrated to be comparably safe and efficacious compared to conventional ablation and resulted in reduced procedure time and radiation exposure. Graphical Abstract Central Illustration. Safety and Efficacy of Lesion Size Index Guided 50 W Radiofrequency ablation in Patients with Paroxysmal Atrial Fibrillation. A total of 259 patients with paroxysmal atrial fibrillation underwent lesion size index (LSI)-guided radiofrequency ablation were enrolled. High-Power Short-Duration ablation reduced total procedure time, significantly decreased radiation exposure, and had similar recurrence rate of atrial fibrillation.https://doi.org/10.1186/s12872-025-04597-9Paroxysmal atrial fibrillationHigh-power short-duration ablationPulmonary vein isolationRadiofrequency ablation
spellingShingle Xinzhong Li
Zhiwen Xiao
Jiachen Zhang
Xiaobo Huang
Hairuo Lin
Senlin Huang
Yulin Liao
Juefei Wu
Jiancheng Xiu
Jianyong Li
Jianping Bin
Yuegang Wang
Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation
Paroxysmal atrial fibrillation
High-power short-duration ablation
Pulmonary vein isolation
Radiofrequency ablation
title Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation
title_full Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation
title_fullStr Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation
title_full_unstemmed Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation
title_short Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation
title_sort safety and efficacy of lesion size index guided 50 w radiofrequency ablation in patients with paroxysmal atrial fibrillation
topic Paroxysmal atrial fibrillation
High-power short-duration ablation
Pulmonary vein isolation
Radiofrequency ablation
url https://doi.org/10.1186/s12872-025-04597-9
work_keys_str_mv AT xinzhongli safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation
AT zhiwenxiao safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation
AT jiachenzhang safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation
AT xiaobohuang safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation
AT hairuolin safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation
AT senlinhuang safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation
AT yulinliao safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation
AT juefeiwu safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation
AT jianchengxiu safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation
AT jianyongli safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation
AT jianpingbin safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation
AT yuegangwang safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation